Restricted accessResearch articleFirst published online 2024-11
Comprehensive Investigation of Homology and Heterogeneity Between Aurantii Fructus and Aurantii Fructus Immaturus Using Chemometrics Combined with Network Pharmacology
Aurantii Fructus (AF) and Aurantii Fructus Immaturus (AFI) are distinct herbs outlined by the Chinese Pharmacopoeia. They are sourced from the same plant but harvested at different times, resulting in differences in efficacy. It is important to avoid mixing them clinically and to distinguish between the two. Furthermore, dissimilar cultivation conditions may cause variability in the quality of herbs, so it is vital to differentiate drugs from dissimilar origins. In this study, two plants, AF and AFI from different provinces, were comparatively analyzed based on High Performance Liquid Chromatography (HPLC) fingerprints and classified using chemometric methods. The results indicate that the two medicines can be clearly distinguished. Also, AF and AFI grown in different locations can be distinguished. Ten chemical markers were screened, and their variations were determined, including eriocitrin, narirutin, naringin, meranzin hydrate, naringenin, hesperidin, nobiletin, tangeretin, neohesperidin, and poncirin. Subsequent network pharmacology correlated the screened chemical components with the biological network of the organism. The material basis of the difference in efficacy of the two homologous herbs was explored from the perspective of changes in chemical composition. This study provides a reference for formulating quality evaluation standards for AF and AFI and lays a foundation for the efficacy-related quality research of the two.
Get full access to this article
View all access options for this article.
References
1.
WangWY, ZhouH, WangYF, et al.Current policies and measures on the development of traditional chinese medicine in China. Pharmacol Res, 2021; 163:105187; doi: 10.1016/j.phrs.2020.105187
2.
LiuX, JiangW, SuM, et al.Quality evaluation of traditional Chinese medicines based on fingerprinting. J Sep Sci, 2020; 43(1):6–17; doi: 10.1002/jssc.201900365
3.
YangW, ZhangY, WuW, et al.Approaches to establish Q-markers for the quality standards of traditional Chinese medicines. Acta Pharm Sin B, 2017; 7(4):439–446; doi: 10.1016/j.apsb.2017.04.012
4.
YangT, LiX, LanL, et al.Quality evaluation of Keteling capsules based on fingerprinting, multicomponent quantification, and quantitative prediction. Spectrochim Acta A Mol Biomol Spectrosc, 2023; 303:123274; doi: 10.1016/j.saa.2023.123274
5.
ZhangC, ZhengX, NiH, et al.Discovery of quality control markers from traditional Chinese medicines by fingerprint-efficacy modeling: Current status and future perspectives. J Pharm Biomed Anal, 2018; 159:296–304; doi: 10.1016/j.jpba.2018.07.006
6.
YanH, ZouC. Progress and prospect of application of traditional Chinese medicine fingerprint (specific chromatogram) in Chinese Pharmacopoeia (2010–2020). Nan Fang Yi Ke Da Xue Xue Bao, 2022; 42(1):150–155; doi: 10.1212/2/j.issn.1673-4254.2022.01.19
7.
GuL, XieX, WangB, et al.Chemical pattern recognition for quality analysis of lonicerae japonicae flos and lonicerae flos based on ultra-high performance liquid chromatography and anti-SARS-CoV2 main protease activity. Front Pharmacol, 2021; 12:810748; doi: 10.3389/fphar.2021.810748
8.
CaoX, YouG, LiH, et al.Comparative investigation for rotten Xylem (kuqin) and strip types (tiaoqin) of Scutellaria baicalensis georgi based on fingerprinting and chemical pattern recognition. Molecules, 2019; 24(13):2431; doi: 10.3390/molecules24132431
9.
SongB, WangW, LiuR, et al.Geographic differentiation of essential oil from rhizome of cultivated atractylodes lancea by using GC-MS and chemical pattern recognition analysis. Molecules, 2023; 28(5):2216; doi: 10.3390/molecules28052216
10.
JiashuoWU, FangqingZ, ZhuangzhuangLI, et al.Integration strategy of network pharmacology in traditional Chinese medicine: A narrative review. J Tradit Chin Med, 2022; 42(3):479–486; doi: 10.1985/2/j.cnki.jtcm.20220408.003
11.
ZhaoL, ZhangH, LiN, et al.Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol, 2023; 309:116306; doi: 10.1016/j.jep.2023.116306
12.
YuanZ, PanY, LengT, et al.Progress and prospects of research ideas and methods in the network pharmacology of traditional chinese medicine. J Pharm Pharm Sci, 2022; 25:218–226; doi: 10.1843/3/jpps32911
13.
MaksoudS, Abdel-MassihRM, RajhaHN, et al.Citrus aurantium L. Active constituents, biological effects and extraction methods. An updated review. Molecules, 2021; 26(19):5832; doi: 10.3390/molecules26195832
14.
Committee, C. P. Pharmacopoeia of the People’s Republic of China. China Chemical Industry Press: Beijing, China; 2020: pp. 257–258.
15.
FangC, HeJ, XiaoQ, et al.Development of the volatile fingerprint of Qu Aurantii Fructus by HS-GC-IMS. Molecules, 2022; 27(14):4537; doi: 10.3390/molecules27144537
16.
ShuY, HeD, LiW, et al.Hepatoprotective effect of citrus aurantium L. Against APAP-induced liver injury by regulating liver lipid metabolism and apoptosis. Int J Biol Sci, 2020; 16(5):752–765; doi: 10.7150/ijbs.40612
17.
Committee, C.P. Pharmacopoeia of the People’s Republic of China. China Chemical Industry Press: Beijing, China; 2020: p. 258.
18.
WuJ, HuangG, LiY, et al.Flavonoids from Aurantii Fructus immaturus and Aurantii Fructus: Promising phytomedicines for the treatment of liver diseases. Chin Med, 2020; 15:89; doi: 10.1186/s13020-020-00371-5
19.
ZhaoY, ChangYS, ChenP. Differentiation of Aurantii Fructus immaturus from poniciri trifoliatae fructus immaturus using Flow-Injection Mass Spectrometric (FIMS) metabolic fingerprinting method combined with chemometrics. J Pharm Biomed Anal, 2015; 107:251–257; doi: 10.1016/j.jpba.2014.12.035
20.
BaiY, ZhengY, PangW, et al.Identification and comparison of constituents of aurantii fructus and aurantii fructus immaturus by UFLC-DAD-Triple TOF-MS/MS. Molecules, 2018; 23(4):803; doi: 10.3390/molecules23040803
21.
HouF, FanX, GuiX, et al.Development of a variety and quality evaluation method for Amomi fructus using GC, electronic tongue, and electronic nose. Front Chem, 2023; 11:1188219; doi: 10.3389/fchem.2023.1188219
22.
LiY, WuX, MaY, et al.Quantitative analysis of multi-components by single marker method combined with UPLC-PAD fingerprint analysis based on saikosaponin for discrimination of bupleuri radix according to geographical origin. Front Chem, 2023; 11:1309965; doi: 10.3389/fchem.2023.1309965
23.
ZolfaghariF, KhosraviH, ShahriyariA, et al.Hierarchical cluster analysis to identify the homogeneous desertification management units. PLoS One, 2019; 14(12):e0226355; doi: 10.1371/journal.pone.0226355
24.
JangJH. Principal component analysis of hybrid functional and vector data. Stat Med, 2021; 40(24):5152–5173; doi: 10.1002/sim.9117
25.
YangM, LiX, LiZ, et al.Gene features selection for three-class disease classification via multiple orthogonal partial least square discriminant analysis and S-plot using microarray data. PLoS One, 2013; 8(12):e84253; doi: 10.1371/journal.pone.0084253
26.
ZhangC, ZhangR, ChengY, et al.Role of Zhiqiao Chuanlian decoction in the treatment of food accumulation fever: Network pharmacology and animal experiments. Heliyon, 2024; 10(8):e29813; doi: 10.1016/j.heliyon.2024.e29813
27.
HeQ, TangG, HuY, et al.Green and highly effective extraction of bioactive flavonoids from Fructus aurantii employing deep eutectic solvents-based ultrasonic-assisted extraction protocol. Ultrason Sonochem, 2024; 102:106761; doi: 10.1016/j.ultsonch.2024.106761
28.
WeiX, JingJ, HuangR, et al.QFAE-nB alleviates pulmonary fibrosis by inhibiting the STING pathway in mice. J Ethnopharmacol, 2024; 319(Pt 2):117295; doi: 10.1016/j.jep.2023.117295
29.
ZhouK, WangD, DuX, et al.UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma. Acta Biochim Biophys Sin (Shanghai), 2024; 56(6):916–926; doi: 10.3724/abbs.2024033
30.
TanW, LiY, WangY, et al.Anti-coagulative and gastrointestinal motility regulative activities of fructus aurantii immaturus and its effective fractions. Biomed Pharmacother, 2017; 90:244–252; doi: 10.1016/j.biopha.2017.03.060
31.
WuZ, ZhangS, LiP, et al.Effect of Aurantii Fructus Immaturus Flavonoid on the contraction of isolated gastric smooth muscle strips in rats. Evid Based Complement Alternat Med, 2016; 2016:5616905; doi: 10.1155/2016/5616905PMC4939329
32.
LiL, ZhangS, XinY, et al.Role of Quzhou Fructus Aurantii extract in preventing and treating acute lung injury and inflammation. Sci Rep, 2018; 8(1):1698; doi: 10.1038/s41598-018-20083-z
33.
BaiYF, WangSW, WangXX, et al.The flavonoid-rich Quzhou Fructus Aurantii extract modulates gut microbiota and prevents obesity in high-fat diet-fed mice. Nutr Diabetes, 2019; 9(1):30; doi: 10.1038/s41387-019-0097-6
34.
AhmedOM, FahimHI, AhmedHY, et al.The preventive effects and the mechanisms of action of navel orange peel hydroethanolic extract, naringin, and naringenin in N-Acetyl-p-aminophenol-induced liver injury in wistar rats. Oxid Med Cell Longev, 2019; 2019:2745352; doi: 10.1155/2019/2745352
35.
QiuM, ZhangJ, WeiW, et al.Integrated UPLC/Q-TOF-MS/MS analysis and network pharmacology to reveal the neuroprotective mechanisms and potential pharmacological ingredients of Aurantii Fructus Immaturus and Aurantii Fructus. Pharmaceuticals (Basel), 2024; 17(2):239; doi: 10.3390/ph17020239
36.
TuohongerbiekeA, WangH, WuJ, et al.Xiao Cheng Qi decoction, an ancient chinese herbal mixture, relieves loperamide-induced slow-transit constipation in Mice: An action mediated by gut microbiota. Pharmaceuticals (Basel), 2024; 17(2):153; doi: 10.3390/ph17020153
37.
ChiK, YangS, ZhangY, et al.Exploring the mechanism of Tingli Pill in the treatment of HFpEF based on network pharmacology and molecular docking. Medicine (Baltimore), 2024; 103(16):e37727; doi: 10.1097/MD.0000000000037727
38.
KampromW, TangporncharoenR, VongthaiwanN, et al.Enhanced potent immunosuppression of intracellular adipose tissue-derived stem cell extract by priming with three-dimensional spheroid formation. Sci Rep, 2024; 14(1):9084; doi: 10.1038/s41598-024-59910-x
39.
ZhangZ, HuangY, GuH, et al.Efficacy of befotertinib in non-small cell lung cancer harboring uncommon compound EGFR mutations G719X and S768I: A case report. Front Oncol, 2024; 14:1370666; doi: 10.3389/fonc.2024.1370666
40.
ChakravarthiVP, KhristiV, GhoshS, et al.ESR2 is essential for gonadotropin-induced kiss1 expression in granulosa cells. Endocrinology, 2018; 159(11):3860–3873; doi: 10.1210/en.2018-00608
MalekiMH, Abdizadeh JavazmS, DastghaibS, et al.The effect of quercetin on adipogenesis, lipolysis, and apoptosis in 3T3-L1 adipocytes: The role of SIRT1 pathways. Obes Sci Pract, 2024; 10(2):e752; doi: 10.1002/osp4.752
43.
ZhangY, HeX, WangK, et al.Irisin alleviates obesity-induced bone loss by inhibiting interleukin 6 expression via TLR4/MyD88/NF-κB axis in adipocytes. J Adv Res, 2024; 14:S2090–1232(24)00156-5; doi: 10.1016/j.jare.2024.04.013
44.
OuAH, RosenthalSB, AdliM, et al.Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: A multi-omics replication study. Transl Psychiatry, 2024; 14(1):109; doi: 10.1038/s41398-024-02811-4
45.
LiH, PageAJ. Altered vagal signaling and its pathophysiological roles in functional dyspepsia. Front Neurosci, 2022; 16:858612; doi: 10.3389/fnins.2022.858612
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
